FLiRT Covid Variant Raises Concerns, Should You Be Worried?

In early 2020, the world faced a terrifying unknown: the COVID-19 pandemic. With limited knowledge of the virus and a surge of infections, nations scrambled to contain the crisis. Waves of illness crashed across continents, leaving devastation in their wake. But thanks to tireless efforts, including vaccine development and lockdowns, the world began to emerge from the chaos.

The fight against COVID-19, however, is far from over. New variants, like FLiRT, continue to test global health systems.

About the FLiRT Variant

FLiRT stands for F and L for mutations in one variant, and R and T for mutations in another, both sub-lineages of the Omicron variant. These mutations make FLiRT, particularly KP.2, more contagious than previous Omicron strains. Data from the US Centers for Disease Control and Prevention (CDC) suggests KP.2 is responsible for roughly one in four infections nationwide, while KP.1.1 accounts for about 7.5%.

Symptoms and Risks

FLiRT symptoms mirror other Omicron subvariants: sore throat, cough, fatigue, congestion, runny nose, headache, muscle aches, fever, and potential loss of taste or smell. While causing increased hospitalizations, FLiRT hasn't significantly raised mortality rates, primarily impacting the upper respiratory tract.

With ongoing research on FLiRT, vigilance remains crucial. Prioritize good hand hygiene, mask-wearing, physical distancing, avoiding large gatherings, staying home when sick, and most importantly, vaccination.

India serves as a beacon of hope. WHO data on April 21st showed roughly 29,294 active cases globally, with Russia leading at 16,300. In stark contrast, India reported only 838 active cases and 1 death as of May 4th. This remarkable achievement highlights the effectiveness of robust public health measures, particularly India's high vaccination rate, in curbing COVID-19 variants.

As the world grapples with this evolving virus, unwavering commitment to preventive measures remains paramount to safeguarding public health.